07/29/2025
1:49 PM | TuHURA Biosciences (Subject)
VANGUARD GROUP INC (Filed by)
| Form SCHEDULE 13G | |
06/13/2025
5:15 AM | TuHURA Biosciences (Filer)
| Form D
Notice of Exempt Offering of Securities | |
06/12/2025
6:00 AM | TuHURA Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/03/2025
9:05 AM | KINETA, INC./DE (Subject)
KINETA, INC./DE (Subject)
KINETA, INC./DE (Subject)
TuHURA Biosciences (Filed by)
| Form 425 | |
05/23/2025
7:30 AM | TuHURA Biosciences (Filer)
| Form 424B3 | |
05/23/2025
7:35 AM | TuHURA Biosciences (Filer)
| Form ARS | |
05/14/2025
11:15 PM | TuHURA Biosciences (Filer)
| Form EFFECT | |
05/13/2025
7:10 AM | KINETA, INC./DE (Subject)
KINETA, INC./DE (Subject)
KINETA, INC./DE (Subject)
TuHURA Biosciences (Filed by)
| Form 425 | |
05/08/2025
4:28 PM | TuHURA Biosciences (Filer)
| Form S-4/A | |
05/07/2025
7:28 AM | TuHURA Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/07/2025
7:31 AM | KINETA, INC./DE (Subject)
KINETA, INC./DE (Subject)
KINETA, INC./DE (Subject)
TuHURA Biosciences (Filed by)
| Form 425 | |
Get the Latest News and Ratings for HURA and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for TuHURA Biosciences and its competitors with MarketBeat's FREE daily newsletter. |
05/06/2025
4:22 PM | TuHURA Biosciences (Filer)
| Form S-4/A | |
05/05/2025
7:05 AM | KINETA, INC./DE (Subject)
KINETA, INC./DE (Subject)
KINETA, INC./DE (Subject)
TuHURA Biosciences (Filed by)
| Form 425 | |
04/28/2025
7:05 AM | KINETA, INC./DE (Subject)
KINETA, INC./DE (Subject)
KINETA, INC./DE (Subject)
TuHURA Biosciences (Filed by)
| Form 425 | |
04/08/2025
8:32 AM | KINETA, INC./DE (Subject)
KINETA, INC./DE (Subject)
KINETA, INC./DE (Subject)
TuHURA Biosciences (Filed by)
| Form 425 | |
04/01/2025
7:00 AM | TuHURA Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/01/2025
7:05 AM | TuHURA Biosciences (Subject)
| Form 425 | |
03/31/2025
4:30 PM | TuHURA Biosciences (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/19/2025
6:12 PM | Tendler Craig (Reporting)
TuHURA Biosciences (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
03/19/2025
6:13 PM | Tendler Craig (Reporting)
TuHURA Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2025
7:00 AM | TuHURA Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/12/2025
5:01 AM | TuHURA Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/07/2025
4:17 PM | TuHURA Biosciences (Filer)
| Form S-4
Registration statement under Securities Act of 1933 | |
01/06/2025
4:08 PM | Hoffman Robert E. (Reporting)
TuHURA Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
3:54 PM | Ng George K (Reporting)
TuHURA Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/23/2024
4:00 PM | TuHURA Biosciences (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
12/12/2024
8:03 AM | TuHURA Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/12/2024
8:07 AM | TuHURA Biosciences (Subject)
| Form 425 | |
11/25/2024
7:55 AM | TuHURA Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/15/2024
4:00 PM | TuHURA Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
4:20 PM | TuHURA Biosciences (Filer)
| Form 8-K/A | |
10/25/2024
3:23 PM | CA Patel F&F Investments, LLC (Filed by)
TuHURA Biosciences (Subject)
| Form SC 13G | |
10/25/2024
3:26 PM | KP Biotech Group LLC (Filed by)
TuHURA Biosciences (Subject)
| Form SC 13G | |
10/25/2024
3:28 PM | Patel Samir Rashmikant (Filed by)
TuHURA Biosciences (Subject)
| Form SC 13G | |
10/25/2024
3:30 PM | Theofilos Charles Steve (Filed by)
TuHURA Biosciences (Subject)
| Form SC 13G | |
10/25/2024
3:16 PM | Bianco James A. (Filed by)
TuHURA Biosciences (Subject)
| Form SC 13D | |
10/25/2024
3:20 PM | Patel Vijay (Filed by)
TuHURA Biosciences (Subject)
| Form SC 13D | |
10/22/2024
8:12 PM | TuHURA Biosciences (Issuer)
Yamashita Dennis (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/22/2024
7:33 PM | TuHURA Biosciences (Issuer)
MANUSO JAMES S J (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
10/22/2024
7:36 PM | TuHURA Biosciences (Issuer)
MANUSO JAMES S J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/22/2024
7:38 PM | TuHURA Biosciences (Issuer)
List Alan (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
GENIUS Act: Cancel Your Money? (Ad) A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. Backed by the government but powered by private corporations, this initiative paves the way for digital dollars—programmable, trackable, and outside your control.
Once embedded into apps, banks, and retail systems, opting out may no longer be possible. But there’s still time to protect your financial freedom—if you act before the system goes fully live. Get the free info kit with 3 strategies to sidestep digital dollar control. |
10/22/2024
7:41 PM | TuHURA Biosciences (Issuer)
List Alan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/22/2024
7:44 PM | TuHURA Biosciences (Issuer)
Ng George K (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
10/22/2024
7:47 PM | TuHURA Biosciences (Issuer)
Ng George K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/22/2024
7:50 PM | TuHURA Biosciences (Issuer)
Patel Vijay (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
10/22/2024
7:07 PM | Bianco James A. (Reporting)
TuHURA Biosciences (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/22/2024
7:10 PM | Bianco James A. (Reporting)
TuHURA Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/22/2024
7:13 PM | TuHURA Biosciences (Issuer)
Yamashita Dennis (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
10/22/2024
6:56 PM | Dearborn Dan (Reporting)
TuHURA Biosciences (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/22/2024
7:01 PM | Dearborn Dan (Reporting)
TuHURA Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/21/2024
7:30 AM | TuHURA Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/15/2024
11:15 PM | TuHURA Biosciences (Filer)
| Form EFFECT | |
10/15/2024
3:20 PM | TuHURA Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/15/2024
7:30 AM | TuHURA Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/08/2024
3:05 PM | TuHURA Biosciences (Filer)
| Form POS AM | |
10/08/2024
6:05 AM | TuHURA Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/07/2024
4:19 PM | TuHURA Biosciences (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
10/04/2024
3:05 PM | TuHURA Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/04/2024
3:10 PM | TuHURA Biosciences (Subject)
| Form 425 | |
09/30/2024
4:20 PM | TuHURA Biosciences (Filer)
| Form NT 10-K | |
09/25/2024
4:27 PM | TuHURA Biosciences (Filer)
| Form 424B3 | |
09/25/2024
4:00 PM | TuHURA Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/25/2024
4:05 PM | TuHURA Biosciences (Subject)
| Form 425 | |
09/24/2024
7:35 AM | TuHURA Biosciences (Subject)
| Form 425 | |
09/24/2024
7:30 AM | TuHURA Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/20/2024
3:20 PM | TuHURA Biosciences (Subject)
| Form 425 | |
09/18/2024
7:40 AM | TuHURA Biosciences (Subject)
| Form 425 | |
09/18/2024
7:35 AM | TuHURA Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/11/2024
7:35 AM | TuHURA Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/11/2024
7:40 AM | TuHURA Biosciences (Subject)
| Form 425 | |
09/03/2024
4:25 PM | TuHURA Biosciences (Subject)
| Form 425 | |
09/03/2024
4:20 PM | TuHURA Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/19/2024
8:05 AM | TuHURA Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/19/2024
8:10 AM | TuHURA Biosciences (Subject)
| Form 425 | |
08/13/2024
11:15 PM | TuHURA Biosciences (Filer)
| Form EFFECT | |
08/12/2024
4:01 PM | TuHURA Biosciences (Filer)
| Form S-4/A | |
08/08/2024
4:30 PM | TuHURA Biosciences (Filer)
| Form S-4/A | |
